Posted in | Infectious Diseases

Utilizing weird and wonderful viral vectors

Live event - Wednesday April 24, 2019 10:30am EDT / 3.30pm BST

When it comes to study design in research, specific considerations are required when designing programs of work which aim to assess the safety of viral products.  With an increasing move to utilization of species that are natural pathogens of toxicology species, standard approaches to handling and containment are insufficient.  Creative and adaptable approaches are required to enable assessment of such products without jeopardizing unrelated studies.

This live webinar will provide an overview of the specific considerations and non-clinical safety assessment strategies required for viral-based products.  Additional discussion on the flexibility required for handling and containment of rodent pathogens to ensure safety to staff, while ensuring there is no risk to animals on unrelated studies will be included.

Register for this live webinar and:

  • Receive an introduction to viral vectors
  • Learn about specific considerations for viral vectors
  • Discover non-clinical safety assessment strategies
  • Explore the handling and containment strategies for non-standard vectors with potential risk to animal colonies
  • Ask questions in the Live Q&A session

Presenter - Dr Kirsty Harper, Head of Biologics

Kirsty Harper, Head of Biologics

Other Webinars from Inotiv, Inc.

Life Science Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.